Valeant To Pop Out Paragon To Quell FTC Antitrust Concerns
Valeant Pharmaceuticals International Inc. has agreed to sell its Paragon Holdings I Inc. division to settle claims by the Federal Trade Commission that it violated federal antitrust laws by acquiring the...To view the full article, register now.
Already a subscriber? Click here to view full article